SCHEMBL650953

SCHEMBL650953

O=C(O)CCC(=O)Nc1ncc(C=C2SC(=Nc3ccc4[nH]ncc4c3)NC2=O)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 4/20 0.37
PTPN12 Q05209 4/20 0.37
PTPN22 Q9Y2R2 4/20 0.37
DUSP3 P51452 3/20 0.37
POLB P06746 6/20 0.37
KMT2A Q03164 6/20 0.37
MEN1 O00255 5/20 0.37
P2RX7 Q99572 2/20 0.37
ACHE P22303 1/20 0.36
PTPN5 P54829 1/20 0.36
PTPN11 Q06124 1/20 0.36
MAPT P10636 3/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
CDC25A P30304 1/20 0.36
CDC25B P30305 1/20 0.36
PSMD14 O00487 1/20 0.36
AURKA O14965 1/20 0.36
AURKB Q96GD4 1/20 0.36
INCENP Q9NQS7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10176294 1.00 PTPN7 (0.37) PTPN7PTPN12PTPN22DUSP3POLB
SCHEMBL651495 1.00 PTPN7 (0.37) PTPN7PTPN12PTPN22DUSP3POLB
SCHEMBL10226364 0.94 ALDH1A1 (0.39) PTPN7PTPN12PTPN22DUSP3POLB
SCHEMBL649006 0.94 ALDH1A1 (0.39) PTPN7PTPN12PTPN22DUSP3POLB
SCHEMBL649005 0.94 ALDH1A1 (0.39) PTPN7PTPN12PTPN22DUSP3POLB
SCHEMBL651661 0.89 OGA (0.40) PTPN7PTPN12PTPN22DUSP3POLB
SCHEMBL651660 0.89 OGA (0.40) PTPN7PTPN12PTPN22DUSP3POLB
SCHEMBL10176261 0.89 OGA (0.40) PTPN7PTPN12PTPN22DUSP3POLB
SCHEMBL652616 0.88 PTPN7 (0.49) PTPN7PTPN12PTPN22DUSP3POLB
SCHEMBL10176312 0.88 PTPN7 (0.49) PTPN7PTPN12PTPN22DUSP3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423204-A1 THIAZOLIDINONE DERIVATIVE SBI Biotech Co., Ltd. (JP) 2012-02-29 EP disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 PTPN7 437/4885PTPN12 1722/4885PTPN22 1463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.